N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.
作者信息
Neale Joseph H
出版信息
J Neurochem. 2011 Dec;119(5):891-5. doi: 10.1111/j.1471-4159.2011.07380.x.
Abstract
摘要
相似文献
1
N-acetylaspartylglutamate is an agonist at mGluR₃ in vivo and in vitro.
J Neurochem. 2011 Dec;119(5):891-5. doi: 10.1111/j.1471-4159.2011.07380.x.
2
N-acetylaspartylglutamate is not demonstrated to be a selective mGlu₃receptor agonist.
J Neurochem. 2011 Dec;119(5):896-8. doi: 10.1111/j.1471-4159.2011.07480.x.
3
The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor.
J Pharmacol Exp Ther. 2009 Jul;330(1):212-9. doi: 10.1124/jpet.109.152553. Epub 2009 Apr 23.
4
beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor.
J Neurophysiol. 2001 Mar;85(3):1097-106. doi: 10.1152/jn.2001.85.3.1097.
5
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
J Neurochem. 2011 Aug;118(4):490-8. doi: 10.1111/j.1471-4159.2011.07338.x. Epub 2011 Jul 1.
6
N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.
J Neurochem. 2000 Aug;75(2):443-52. doi: 10.1046/j.1471-4159.2000.0750443.x.
7
Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
Neuropharmacology. 2009 May-Jun;56(6-7):1060-7. doi: 10.1016/j.neuropharm.2009.03.002. Epub 2009 Mar 12.
8
N-acetylaspartylglutamate selectively activates mGluR3 receptors in transfected cells.
J Neurochem. 1997 Jul;69(1):174-81. doi: 10.1046/j.1471-4159.1997.69010174.x.
9
Regional distribution and pharmacological characteristics of [3H]N-acetyl-aspartyl-glutamate (NAAG) binding sites in rat brain.
Neurochem Int. 2001 Jan;38(1):53-62. doi: 10.1016/s0197-0186(00)00045-0.
10
Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
J Neurochem. 2005 May;93(3):605-10. doi: 10.1111/j.1471-4159.2005.03041.x.
引用本文的文献
1
Effect of LPJZ-658 on caecum microbiota and serum metabolomics of Luhua broiler.
Front Microbiol. 2025 Aug 20;16:1622009. doi: 10.3389/fmicb.2025.1622009. eCollection 2025.
2
Post-methamphetamine working memory decline predicts relapse vulnerability in rats and is rescued by mGlu3 receptor activation.
Psychopharmacology (Berl). 2025 Jul 18. doi: 10.1007/s00213-025-06847-2.
3
Aspartate in the Brain: A Review.
Neurochem Res. 2025 Jun 12;50(3):199. doi: 10.1007/s11064-025-04454-3.
4
Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.
Cell Biosci. 2024 Apr 6;14(1):45. doi: 10.1186/s13578-024-01224-6.
5
Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders.
Pharmacol Biochem Behav. 2022 Nov;221:173493. doi: 10.1016/j.pbb.2022.173493. Epub 2022 Nov 17.
6
Recent Advances in the Modulation of Pain by the Metabotropic Glutamate Receptors.
Cells. 2022 Aug 21;11(16):2608. doi: 10.3390/cells11162608.
7
Group II Metabotropic Glutamate Receptors Reduce Apoptosis and Regulate BDNF and GDNF Levels in Hypoxic-Ischemic Injury in Neonatal Rats.
Int J Mol Sci. 2022 Jun 23;23(13):7000. doi: 10.3390/ijms23137000.
8
Glutamate Metabotropic Receptor Type 3 (mGlu3) Localization in the Rat Prelimbic Medial Prefrontal Cortex.
Front Neuroanat. 2022 Apr 4;16:849937. doi: 10.3389/fnana.2022.849937. eCollection 2022.
9
-Acetyl-Aspartyl-Glutamate in Brain Health and Disease.
Int J Mol Sci. 2022 Jan 23;23(3):1268. doi: 10.3390/ijms23031268.
10
Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis.
Neurotherapeutics. 2022 Jan;19(1):274-288. doi: 10.1007/s13311-021-01159-7. Epub 2022 Jan 4.
本文引用的文献
1
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
J Neurochem. 2011 Aug;118(4):490-8. doi: 10.1111/j.1471-4159.2011.07338.x. Epub 2011 Jul 1.
2
N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate.
J Biol Chem. 2011 May 13;286(19):16693-706. doi: 10.1074/jbc.M111.230136. Epub 2011 Mar 25.
3
Endogenous N-acetylaspartylglutamate (NAAG) inhibits synaptic plasticity/transmission in the amygdala in a mouse inflammatory pain model.
Mol Pain. 2010 Sep 22;6:60. doi: 10.1186/1744-8069-6-60.
4
Sensing G protein-coupled receptor activation.
Neuropharmacology. 2011 Jan;60(1):45-51. doi: 10.1016/j.neuropharm.2010.08.006. Epub 2010 Aug 18.
5
Metabotropic glutamate receptors: physiology, pharmacology, and disease.
Annu Rev Pharmacol Toxicol. 2010;50:295-322. doi: 10.1146/annurev.pharmtox.011008.145533.
6
The neuroactive peptide N-acetylaspartylglutamate is not an agonist at the metabotropic glutamate receptor subtype 3 of metabotropic glutamate receptor.
J Pharmacol Exp Ther. 2009 Jul;330(1):212-9. doi: 10.1124/jpet.109.152553. Epub 2009 Apr 23.
7
Effects of N-acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR.
Neuropharmacology. 2009 May-Jun;56(6-7):1060-7. doi: 10.1016/j.neuropharm.2009.03.002. Epub 2009 Mar 12.
8
Glutamatergic inhibition in sensory neocortex.
Cereb Cortex. 2009 Oct;19(10):2281-9. doi: 10.1093/cercor/bhn246. Epub 2009 Jan 28.
9
Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
Mol Pain. 2008 Aug 1;4:31. doi: 10.1186/1744-8069-4-31.
10
Progress in the discovery and development of glutamate carboxypeptidase II inhibitors.
Drug Discov Today. 2007 Sep;12(17-18):767-76. doi: 10.1016/j.drudis.2007.07.010. Epub 2007 Aug 27.
Zotero 插件